¤d¸U§O§â¶À´³³¡¯fÅÜ·í¦¨¥¿±`¦Ñ¤Æ¡I²´¬ìÂå®vÃn±`¨£2¤j¶À´³³¡¯fÅÜÃþ«¬ªvÀø·sÁͶÕ

2023-10-04 2105

ªü©i´µ°Ç¤è®æªí¡AÀË´ú¦Û¨­ªºµø¤Oª¬ºA¡A¤d¸U§O§â¶À´³³¡¯fÅÜ·í¦¨¥¿±`ªº¦Ñ¤Æµ²ªG¡A¦pªG¨S¦³ªvÀø¡Aµø¤O¥i¯à·|ÀHµÛ¯fµ{µo®i¦Ó¨ü·l©Î³à¥¢¡A¤Î®É¥Bí©wªºªvÀø®æ¥~­«­n¡C

64·³ªº¼B¥ý¥Í¡A4¦~«e³z¹L®a¤H±a¦^®a¤¤ªºªü©i´µ°Ç¤è®æªí¡AÀË´ú¦Û¨­ªºµø¤Oª¬ºA¡A°Z®Æ¡A¦Û»{µø¤O¥¿±`ªº¥L¡A¥k²´³æ²´µø³¥³ºµo¥Í§á¦±¡A³s®a¤Hªº¤­©x³£¬Ý¤£²M·¡¡C³Y²§ªº¥L¡A¥ß¨è¨ìªL¤fªø©°¬ö©ÀÂå°|²´¬ì³¡¶À«³­×³¡ªøªº¶E¶¡Àˬd¡A½T¶E¬°Àã©Ê¦~ÄÖ¬ÛÃö©Ê¶À´³³¡°h¤Æ¯fÅÜ¡C©Ò©¯³z¹L¿n·¥ªvÀø¡B¦^¶E°lÂÜ¡A¯e¯fí©w±±¨î¦Ü¤µ¡C

ªL¤fªø©°¬ö©ÀÂå°|²´¬ì³¡¶À«³­×³¡ªø»¡©ú¡A³y¦¨µø¤O»Ùê¡B¥¢©úªº5¤j¥D¦]¥]¬A¡G¦~ÄÖ¬ÛÃö©Ê¶À´³³¡°h¤Æ¯fÅÜ¡B¿}§¿¯fµøºô½¤¯fÅÜ¡B©}¥ú¤£¥¿¡B«C¥ú²´¡B¥Õ¤º»Ù¡A¨ä¤¤»P¶À´³³¡¡þµøºô½¤¯fÅܬÛÃö´N¥e2¦ì¡C¤£¶È¦p¦¹¡A¦³µø¤O»Ùꪺ¦Ñ¦~¤H¤¤¡A¨C4¤H´N¦³1¤H¬O¶À´³³¡¯fÅܤް_¡A¦Ó¨C10¦ìªø½ú¤¤¬ù¦³1¦ìªº¥¢©ú·½©ó¶À´³³¡¯fÅÜ¡C

¶À«³­×³¡ªø±j½Õ¡A¤d¸U§O§â¶À´³³¡¯fÅÜ·í¦¨¥¿±`ªº¦Ñ¤Æµ²ªG¡A¦pªG¨S¦³ªvÀø¡Aµø¤O¥i¯à·|ÀHµÛ¯fµ{µo®i¦Ó¨ü·l©Î³à¥¢¡A¤Î®É¥Bí©wªºªvÀø®æ¥~­«­n¡CµM¦Ó¡A¹O¥b¼Æ±wªÌ¦bªvÀø¨â¦~«á°±¤îÀøµ{ ¡A­YµL«ùÄò¦^¶E¥i¯à¼ÉÅS©óµø¤O¨ü·l»P¥¢©úªº¦M¾÷¤¤¡C

¶À«³­×³¡ªø¶i¤@¨B¸ÑÄÀ¡A¶À´³³¡¯fÅÜ¥i¨Ì¾Ú¨ä­P¯f­ì¦]¤À¬°³\¦hºØ¡A±`¨£ªºÃþ«¬¥]§t¡GÀã©Ê¦~ÄÖ¬ÛÃö©Ê¶À´³³¡°h¤Æ¯fÅÜ¡]Neovascular Age-related Macular Degeneration, nAMD¡^»P¿}§¿¯f¶À´³³¡¤ô¸~¡]Diabetic Macular Edema, DME¡^¡C«eªÌªºµo¯f¾÷²vÀH¦~ÄÖ¼Wªø¦Ó´£¤É¡A«áªÌ«h¬O¦nµo©ó¿}§¿¯f±wªÌ¡C­È±oª`·Nªº¬O¡AÀã©Ê¦~ÄÖ¬ÛÃö©Ê¶À´³³¡°h¤Æ¯fÅܱwªÌ¦]¯ßµ¸½¤¤¤ªº¦åºÞ²§±`¼W¥Í¥Bµ²ºc¤£ºò±K¡A©Ò¥H¤ô¤À¡B¦å²G®e©ö±q²Ó­M¶¡ªºÁ_»Øº|¥X¡A³y¦¨¤ô¸~¡B¥X¦å¡C

¶À«³­×³¡ªø´£¿ô¡AÀHµÛ¯fµ{µo®i¡A§Ú­Ìªº¡uµø¡v¬É±NÅܱo¼Ò½k¡B§á¦±¡B¥X²{¶ÂÂI¡BÃC¦âÅf²H¡C¤]´£¿ô¥Á²³¡A¤d¸U§O¥H¬°µø½uÅÜ®t¤@ÂIÂI¨SÃö«Y¡A­Yµø³¥¨ü¨ì­­¨î¡A¤£¶È¾r¾p¥æ³q¤u¨ã®É®e©ö¦³¦MÀI¡A¥i¯à³s¨«¼Ó±è³£·|½òªÅ¡A¾\Ū¡B¤u§@µ¥¤]³£·|¨ü¨ì½ÄÀ»¡A¥i¯à¼vÅT¤é±`¥Í¬¡«~½è»P¦w¥þ¡C

¦bªvÀø¤è­±¡A°£¤F¶Ç²Î²´¤ºª`®gªvÀø¡A¥Ø«e°w¹ïÀã©Ê¦~ÄÖ¬ÛÃö©Ê¶À´³³¡°h¤Æ¯fÅÜ»P¿}§¿¯f¶À´³³¡¤ô¸~ªºªvÀø¡A¤w¦³·s¤@¥NÂù¾÷Â಴¤ºª`®gÃĪ«¡A¦³¾÷·|¥iÀ°§U´î¤Ö¤£¥¿±`¦åºÞ¼W¥Í¨ÃÅý¦åºÞ§óí©w¡C

¶À«³­×³¡ªø¹ªÀy±wªÌ¥i¨Ì¾ÚÂåÅñ¤Î¦Û¨­»Ý¨D¡A¿ï¾Ü¾A¦XªºÀøµ{¡C³z¹LÃĪ«·s¿ï¾Ü¡A¦³±æ±NªvÀøÀW²v©µªø¦Ü¨C4­Ó¤ë1¦¸¡A´î¤Ö²´¤ºª`®g¦¸¼Æ¡AÀ°§U±wªÌ¦bªvÀø«e´Á´N«Ø¥ß«H¤ß¡A«P¨Ï¨ä¥¼¨ÓªvÀø§óí©w¡A¦P®É¤]´î»´¤F·ÓÅ@ªÌªº­t¾á¡A»Ý­n¤W¯Zªº¨ä¥L®a®x¦¨­û¤]¥i¥H»´ÃP³­¦ñ±wªÌ§Ü¯f¡C¡]³¯¦pÀ[¡þ¥x¥_³ø¾É¡^

¡iªü©i´µ°Ç¤è®æªí¡j

¡¶³z¹Lªü©i´µ°Ç¤è®æªí¦Û§ÚÀˬd¶À´³³¡¯fÅÜ¡C¡]¹Ï¡þ¤¤µØ¥Á°ê·Rª¼¨ó·|´£¨Ñ¡^

¡]¹Ï¡þ¤¤µØ¥Á°ê·Rª¼¨ó·|´£¨Ñ¡^
¨Ó·½¡G¤d¸U§O§â¶À´³³¡¯fÅÜ·í¦¨¥¿±`¦Ñ¤Æ¡I²´¬ìÂå®vÃn±`¨£2¤j¶À´³³¡¯fÅÜÃþ«¬ªvÀø·sÁͶÕ
¥X³B¡GNOW°·±d

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');